The global Alpha-1 Lung Disease Market is estimated to be valued at US$ 4.99 billion in 2023 and is expected to exhibit a CAGR of 18.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Alpha-1 lung disease refers to a genetic disorder that causes lung and liver damage. It is characterized by the deficiency of alpha-1 antitrypsin (AAT) protein, which in turn leads to the destruction of lung ... Read more
